Open Access
- 31 July 2020
- journal article
- review article
- Published by Universitas Airlangga in Berkala Ilmu Kesehatan Kulit dan Kelamin
- Vol. 32 (2) , 149-157
Abstract
Background: Leprosy is a chronic infectious disease caused by Mycobacterium leprae, which tends to attack peripheral nerves and skin. The diagnosis of leprosy is based on the presence of one of three cardinal signs. Early diagnosis of leprosy is critical and is made through clinical examination and investigation. Purpose: To discuss the diagnosis, laboratory examination, and treatment of leprosy, considering that early diagnosis and appropriate treatment are the key elements in breaking the chain of transmission and preventing leprosy patients' disabilities. Review: Leprosy is a chronic granulomatous infectious disease caused by the Mycobacterium leprae. Based on clinical appearance, histopathology findings, and immunological, leprosy is grouped into six forms using the Ridley-Jopling classification, namely Tuberculoid (TT), Borderline Tuberculoid (BT), Borderline-borderline Mid-borderline (BB), Borderline-lepromatous (BL), Subpolar Lepromatous (LLs), and Polar Lepromatous (LLp). Based on the treatment category, leprosy is grouped into paucibacillary (PB) and multibacillary (MB). Leprosy is often diagnosed clinically, and skin scraping smear remains the preferred laboratory method. The negative results of smear skin scraping may not necessarily exclude leprosy. Therefore, a higher sensitivity test might be needed to detect M. leprae. Treatment with Multi-Drug Therapy (MDT) is adjusted based on the type of leprosy, whether it belongs to the PB or MB group. Treatment of PB type, regimens are rifampicin and dapsone, while in MB type, the patients received rifampicin, dapsone, and clofazimine regimens. Conclusion: A proper diagnosis for leprosy, both through physical examination and laboratory examination, is required to determine an effective MDT treatment and break the chain of disease transmission.Keywords
This publication has 26 references indexed in Scilit:
- Anti-PGL-1 Positivity as a Risk Marker for the Development of Leprosy among Contacts of Leprosy Cases: Systematic Review and Meta-analysisPLOS Neglected Tropical Diseases, 2016
- Integrative literature review of the reported uses of serological tests in leprosy managementRevista da Sociedade Brasileira de Medicina Tropical, 2016
- A historical overview of leprosy epidemiology and control activities in Amazonas, BrazilRevista da Sociedade Brasileira de Medicina Tropical, 2015
- Leprosy: a review of laboratory and therapeutic aspects - Part 2Anais Brasileiros de Dermatologia, 2014
- The Challenge of Producing Skin Test Antigens with Minimal Resources Suitable for Human Application against a Neglected Tropical Disease; LeprosyPLOS Neglected Tropical Diseases, 2014
- Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - Part 1Anais Brasileiros de Dermatologia, 2014
- Clinico-histopathological correlation of skin biopsies in leprosyJournal of Pathology of Nepal, 2013
- Adverse effects of alternative therapy (minocycline, ofloxacin, and clofazimine) in multibacillary leprosy patients in a recognized health care unit in Manaus, Amazonas, BrazilAnais Brasileiros de Dermatologia, 2013
- Newer management options in leprosyIndian Journal of Dermatology, 2013
- Leprosy: An Overview of PathophysiologyInterdisciplinary Perspectives on Infectious Diseases, 2012